编辑：穆皓 在这场跨越山河的极限征途中，津药达仁堂以传承五百年的中医药智慧，为车手们打造移动的 "健康守护站"。针对旅途常见不适，量身定制的健康包涵盖 速效救心丸、清咽滴丸、胃肠安丸、藿香正气软胶囊、京万红软膏以及风油精等多款经典国药，从呼吸、消化、急救、外用等多个维度，全方位守护车手们 的征途健康。在广东省湛江市南三岛的高温中突然的胸闷气短，含服速效救心丸后有所舒缓，休息片刻便继续前行；穿越甘肃省张掖市大地之树峡谷时长时 间干燥引发的喉咙干痒刺痛，含上清咽滴丸后疼痛减弱，继续向前奔赴下一站。 当数字科技赋能汽车赛事，当无畏探索遇上国药守护，津药达仁堂集团以现代中药的专业力量，让车手们得以心无旁骛挑战极限、逐梦山河。每一公里的驰 骋，都是科技与勇气的双重彰显；每一次的突破，都离不开专业守护的坚实支撑。这场破万里程的数字环驾之旅，既展现了中国汽车产业的硬核科技实力， 更书写了五百年中医药与现代赛事的跨界相融新篇章。以国药之力护航征途，以敬畏之心丈量中国，"2025 中国数字汽车大赛・数字环驾中国大赛" 的精彩 仍在继续，更多山河盛景与挑战突破，值得共同期待！（李禹霏） 转自：新华财经 2025年11月17日，" ...

Core Viewpoint - The company, Kang En Bei, is actively expanding its international business, particularly in the field of anti-infection raw materials and traditional Chinese medicine formulations, achieving competitive advantages and making significant progress in international registrations and exports [1] Group 1: International Business Expansion - The company sells products to multiple countries, including Italy and Germany within the EU [1] - The company has developed a competitive advantage in the internationalization of anti-infection raw materials after years of effort [1] - The company is actively expanding its traditional Chinese medicine formulation business internationally [1] Group 2: Product Registration and Export - The company has completed international registrations for several products, including Plurolan tablets/capsules, Chuanlian Ning tablets, Jixuegan cream, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun export sales [1] - The company plans to adjust product forms to expand into different international markets [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun to be exported [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the "Belt and Road" initiative, to expand its international market [1]

Core Viewpoint - The company emphasizes the importance of expanding its international business, particularly in the field of active pharmaceutical ingredients (APIs) for anti-infection products and traditional Chinese medicine formulations [1] Group 1: International Business Expansion - The company has developed a competitive advantage in the internationalization of APIs in the anti-infection sector after years of effort [1] - The company is actively expanding its international market for traditional Chinese medicine formulations [1] Group 2: Product Registration and Certification - The company has completed international registrations for several products, including Plavix tablets/capsules, Intestinal Tract Ning tablets, Jixuegan ointment, and Fengyoujing [1] - Ginkgo biloba extract has obtained the CEP certificate from EDQM, and related products have begun exporting [1] Group 3: Market Strategy - The company plans to adjust product forms for different markets and leverage national strategies and policy support, such as the Belt and Road Initiative, to expand its international market [1]

Core Viewpoint - The article highlights the significant movement in "Cross-Strait" concept stocks in the capital market, particularly focusing on Fujian Province's listed companies, which are gaining attention due to their strong industrial foundations and innovative strategies [1]. Group 1: Company Overview - Qingshan Paper (600103.SH) is a state-controlled listed company with over 60 years of development, leading in the green paper and pharmaceutical sectors through a dual-driven strategy [1]. - The company has established a diversified industrial structure that includes pulp, paper, cogeneration, pharmaceuticals, and optoelectronics, making it a key player in the packaging paper and textile dissolving pulp sectors [1]. Group 2: Innovation and Development - Qingshan Paper has recently established an academic expert workstation to address industrial technology bottlenecks and enhance future development, aligning with the bamboo industry chain's strategic initiatives in Sanming City [2]. - The company aims to create a deep integration of production, education, research, and application through this workstation, positioning itself as a core engine for high-quality development in the bamboo industry [2]. Group 3: Environmental and Sustainable Practices - The company has integrated green development principles throughout its operations, implementing comprehensive environmental emergency plans and pollution control facilities [3]. - Qingshan Paper is committed to enhancing its bamboo pulp application scenarios and optimizing production processes to develop more bamboo-based products, thereby converting regional bamboo resource advantages into industrial and economic benefits [3]. Group 4: Market Opportunities - The ongoing development of the Cross-Strait integration demonstration zone presents both policy and market opportunities for local Fujian enterprises [3]. - With a clear green development strategy, strong technological innovation capabilities, and resource integration advantages, Qingshan Paper is expected to lead in the high-value utilization of bamboo resources, contributing to the region's economic growth [3].

Core Viewpoint - The article highlights the significant movement in "Cross-Strait" concept stocks in the capital market, particularly focusing on Fujian Province's listed companies, which are gaining attention due to their solid industrial foundations and innovative strategies [1]. Group 1: Company Overview - Qingshan Paper Industry (600103.SH) has over 60 years of development and is a state-controlled listed company, leading with a dual-driven strategy of "green papermaking and meticulous pharmaceuticals" [1]. - The company has established a diversified industrial structure that includes pulp, paper, cogeneration, pharmaceuticals, and optoelectronics, making it a key player in the production of packaging paper and dissolving pulp in China [1]. Group 2: Innovation and Development - Innovation is identified as a crucial factor for the company to overcome development bottlenecks, with the recent establishment of an academician expert workstation aimed at addressing technical challenges and enhancing future growth [2]. - The company aims to create a deep integration of production, education, research, and application through this workstation, positioning itself as a core engine for the high-quality development of the bamboo industry in Sanming [2]. Group 3: Environmental and Sustainable Practices - The company has integrated green development principles throughout its operations, implementing comprehensive environmental emergency plans and pollution control facilities to ensure compliance with environmental standards [3]. - Qingshan Paper Industry is committed to enhancing its bamboo pulp applications and optimizing production processes to convert Fujian's bamboo resource advantages into industrial and economic benefits [3]. Group 4: Market Opportunities - The ongoing development of the Cross-Strait integration demonstration zone presents both policy and market opportunities for local Fujian enterprises, with Qingshan Paper Industry positioned to lead in the high-value utilization of bamboo resources [3]. - The company's clear green development strategy, strong technological innovation capabilities, and resource integration advantages are expected to contribute significantly to the high-quality development of the regional economy [3].

Core Viewpoint - The incident involving a woman who suffered burns from a homemade solution of vinegar and sugar highlights the potential dangers of following unverified life hacks for cleaning, emphasizing the need for scientific understanding of such methods [1][2][3][4] Group 1: Chemical Reactions and Safety - The use of white vinegar to remove limescale is scientifically valid, as vinegar (acetic acid) reacts with calcium carbonate and magnesium hydroxide in limescale to produce soluble compounds [1] - The woman's burns were caused by the high temperature of the solution and the rapid production of carbon dioxide gas, which increased pressure in the sealed thermos, leading to an explosive release [1][2] - To safely use vinegar for descaling, it is advised to keep the thermos open and use room temperature vinegar, avoiding the introduction of high-temperature liquids into sealed containers [2] Group 2: Common Household Hazards - Mixing toilet cleaner (containing hydrochloric acid) with bleach (sodium hypochlorite) can produce toxic chlorine gas, posing serious health risks such as respiratory distress and potential fatality [3] - The combination of cleaning agents like toilet cleaner and dish soap can neutralize each other, reducing cleaning effectiveness [3] - Other popular life hacks, such as using matches to enhance mosquito repellent, can also be dangerous due to the flammable nature of the components involved [2][3] Group 3: General Advice on Life Hacks - While some online life hacks may be effective, it is crucial to verify their scientific basis and understand the underlying principles before attempting them [4]

Core Points - The article discusses the emergence of the "hidden wing bug" in Shandong, highlighting its potential danger and providing a safety manual for the public [2][4]. Identification and Characteristics - The hidden wing bug measures 0.6-0.8 cm in length, resembling a large ant, with a black head and abdomen, orange-yellow thorax and legs, and inconspicuous wings [4]. - It prefers light and moisture, often found in rice fields, grasslands, and forests, and is attracted to light at night [4]. Behavior and Effects - The bug does not bite but releases a strong acidic venom (pH 1-2, comparable to concentrated sulfuric acid) when crushed [6]. - The venom causes delayed reactions: redness and burning on the first day, increased swelling and pain on the second day, and possible yellow pus and severe itching on the third day [7][8]. Prevention and Response - To avoid contact, individuals are advised to gently blow or use a card to remove the bug instead of swatting it [9][10]. - In case of contact, immediate washing with plenty of water or soap is recommended to neutralize the venom [11]. - For initial symptoms, treatments include applying calamine lotion for itching and using saline solution for blisters [12]. - If severe symptoms occur, such as pus or intense pain, seeking medical attention is crucial [13]. Preventive Measures - Maintain cleanliness by clearing debris and weeds around homes to reduce habitats for the bug [14]. - Close windows and curtains at night to minimize light attraction [14]. - Wear long sleeves and pants when outdoors to protect skin [14]. - Use insecticides containing "permethrin" or "pyrethroids" in key areas to create a protective barrier [14].

Group 1 - The stock of Qingshan Paper (600103) has reached a limit-up on November 11, trading at 3.8 yuan per share, with over 560,000 hands on the limit-up board [1] - In the past five trading days, the stock has achieved four limit-ups, indicating strong market interest [1] - As of September 5, 2025, the cumulative increase in the company's stock price is 25.91%, with a turnover rate of 18.30% on September 10 [1] Group 2 - The company is primarily engaged in the production and trade of bamboo wood pulp, dissolving pulp, paper bag paper, paper products, optoelectronic products, pharmaceutical products, and timber products [1] - Key products include "Qingshan brand" series of stretchable paper bag paper, environmentally friendly paper bag paper, refined kraft packaging paper, dissolving pulp, bamboo wood pulp, and various optoelectronic components [1] - The company has confirmed that its production and operational activities are normal, with no significant changes in daily operations [1] Group 3 - The company has not identified any media reports or market rumors that could significantly impact its stock trading price, nor is it involved in any trending concepts [1]

Core Viewpoint - Fujian Qingshan Paper Industry Co., Ltd. has experienced significant stock price fluctuations, with a cumulative increase of 37.45% since September 1, 2025, and 25.91% since September 5, 2025, leading to a warning about abnormal trading behavior [2][3]. Group 1: Stock Trading Abnormalities - The company's stock price increased by over 20% for three consecutive trading days (September 5, 8, and 9, 2025), qualifying as abnormal trading behavior according to Shanghai Stock Exchange regulations [2][3]. - On September 10, 2025, the stock closed at the daily limit price of 3.45 yuan per share, with a turnover rate of 18.30% [2][3]. Group 2: Company Operations - The company is engaged in the production and sale of various products, including bamboo pulp, dissolving pulp, paper bag paper, and electronic products, with normal operational activities reported [4]. - There have been no significant changes in the company's daily operations [4]. Group 3: Major Events and Information Disclosure - The company has confirmed that there are no undisclosed major events or information that could impact its stock, including asset restructuring or significant business collaborations [5]. - No media reports or market rumors have been identified that could significantly affect the stock price [6]. Group 4: Board of Directors Statement - The board of directors has stated that there are no undisclosed matters that should be reported according to the Shanghai Stock Exchange rules, and previous disclosures do not require correction or supplementation [7].